These cases of people with hemophilia (PWH) illustrate the importance of understanding the patient's expectations and desires and adapting treatment to meet these needs, in addition to traditional clinical targets. Population PK modeling and FVIII products with improved PK profiles provide the opportunity to individualize care and improve long-term outcomes.
Jackson, S., Santoro, C., Gue, D., Ferretti, A., Gaglioti, D., Squire, S., Mazzucconi, M. G., & Hermans, C. (2019). Clinical practice of personalized prophylaxis in hemophilia: Illustrations of experiences and benefits from two continents. Clinical Case Reports, 7(4), 689-694. https://doi.org/10.1002/ccr3.2021 (Original work published 2019)